Suppliers / Tianjin Minxiang Pharmaceutical

Tianjin Minxiang Pharmaceutical

China Updated 9 July 2026

Tianjin Minxiang Pharmaceutical is an API manufacturer based in China. It holds one active US drug master file and one valid CEP across a filed portfolio of 2 molecules.

1
active US DMFs
1
valid CEPs
1
registered plants
0
filings across 0 regulators

Registered plants

Site FDA FEI
Jinghai, China Not on file

What they file, and where

Molecule Regulators Docs
Timolol EDQM 1
Vildagliptin US FDA 1

Also appears on these molecule pages

Questions about Tianjin Minxiang Pharmaceutical

Does Tianjin Minxiang Pharmaceutical hold a US DMF or a CEP?
Tianjin Minxiang Pharmaceutical holds 1 active US drug master file and 1 valid CEP. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
Where does Tianjin Minxiang Pharmaceutical manufacture?
1 registered site is on record, in China (Jinghai). Every site is listed on this page with the register it came from.
What does Tianjin Minxiang Pharmaceutical make?
2 molecules are on record against Tianjin Minxiang Pharmaceutical, including Timolol and Vildagliptin. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Tianjin Minxiang Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability